July 1 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Monday that the European Union drug regulator has accepted a market authorisation application for its investigational COVID-19 prevention ...
AstraZeneca Plc's AZN supplemental New Drug Application for Tagrisso (osimertinib) in combination with chemotherapy has been accepted and granted Priority Review in the U.S. for locally advanced or ...
AstraZeneca (NASDAQ:AZN) and partner Daiichi Sanyko (OTCPK:DSKYF)(OTCPK:DSNKY) said the FDA has accepted their application with priority review for expanded approval of Enhertu for the treatment of ...
AstraZeneca said it and Daiichi Sankyo decided to voluntarily withdraw the marketing authorization application in the European Union for advanced lung-cancer treatment Dato-DXd. This decision followed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback